Biomarker-Guided strategy aims to slow kidney decline in CKD patients
Disease control
Recruiting now
This study tests whether using specific biomarkers to guide treatment choices can better slow the loss of kidney function in people with chronic kidney disease (CKD) compared to standard care. About 125 adults with CKD and elevated protein in their urine will receive either a tai…
Phase: PHASE4 • Sponsor: Peter Rossing • Aim: Disease control
Last updated May 26, 2026 12:03 UTC